No Data
In 2024, Eli Lilly and Co (LLY.US) shines brightly while Novo-Nordisk A/S (NVO.US) fades into the background.
As the year comes to a close, Wall Street has listed Eli Lilly and Co (LLY.US) as one of the best-performing companies among large pharmaceutical firms, while Novo-Nordisk A/S (NVO.US) has lagged due to a bleak outlook.
Eli Lilly to End 2024 Among Best in Big Pharma; Novo Among Worst
Elon Musk Admits To Using Weight Loss Medication Criticized By RFK Jr, Says He Prefers Mounjaro Over Miracle Drug Ozempic
Behind the Scenes of Novo Nordisk's Latest Options Trends
Here's Why Novo Nordisk A/S (NVO) Slid in Q3
US MOVERS&SHAKERS Dec 23-Dec 27, 2024
